Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytesis a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes

Citation
Ps. Heeger et al., Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytesis a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes, J IMMUNOL, 163(4), 1999, pp. 2267-2275
Citations number
45
Categorie Soggetti
Immunology
Journal title
JOURNAL OF IMMUNOLOGY
ISSN journal
00221767 → ACNP
Volume
163
Issue
4
Year of publication
1999
Pages
2267 - 2275
Database
ISI
SICI code
0022-1767(19990815)163:4<2267:PFODIL>2.0.ZU;2-7
Abstract
While matching for MHC Ags improves renal allograft survival, closely match ed grafts sometimes fail due to rejection, and poorly matched allografts ar e often well tolerated by the recipient. The severity of the rejection proc ess may partially depend on the presence of environmentally primed T cells in the recipient that cross-react with donor Ags, To test for the presence of primed, donor-specific T cells in humans before transplantation, we used an enzyme-linked immunospot assay for detection of allospecific cytokines produced by individual human PBLs, We demonstrate that this approach detect s cytokine production at single cell resolution and detects production of I FN-gamma only when there is defined immunologic priming, thus representing a measure of primed donor-specific immunity. Because the environmental Ag e xposure of the recipient is not a function of the HLA mismatch between dono r and potential recipient, the number of HLA mismatches may not correlate w ith the frequency of pretransplant, donor-specific IFN-gamma-producing PBLs , Studies of donor-specific IFN-gamma-producing lymphocytes in a cohort of patients being evaluated for renal transplantation corroborated this hypoth esis. Moreover, for recipients of both living and cadaver renal allografts, the pretransplant frequency of donor-specific memory cells correlated with the posttransplant risk of developing acute rejection episodes. This impro ved ability to define the strength of the allospecific immune response by e nzyme-linked immunospot assay may allow improved pairing of recipients with donors and identification of kidney allograft donor-recipient pairs at hig h risk for acute rejection, thus permitting targeted interventions aimed at prolonging graft survival.